As a liquid biopsy company, LIQOMICS is transforming oncology with non-invasive ctDNA analysis for cancer monitoring and treatment optimization. Our circulating tumor DNA (ctDNA) tests provide:
✔ Ultra-sensitive detection of minimal residual disease (MRD)
✔ Real-time insights into tumor genetics from a simple blood draw
✔ Exceptional precision for tracking treatment response
We empower clinicians to make data-driven decisions for lymphomas, solid tumors, and other malignancies by eliminating the need for invasive biopsies. Discover how our liquid biopsy technology is redefining cancer management.
Company Details
- Employees
- 6
- Founded
- 2021
- Address
- Neurather Ring 1, Cologne,north Rhine-Westphalia 51063,germany
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://liqomics.com
- HQ
- Cologne, North Rhine-Westphalia
Liqomics Questions
Liqomics's website is https://liqomics.com
Liqomics's LinkedIn profile is https://de.linkedin.com/company/liqomics
Liqomics has
6 employees.
View email and phone details for 6
employees at Liqomics.
Liqomics's industry is
Medical and Diagnostic Laboratories
Liqomics's top competitors are
Miltenyi Biotec,
Illucens Gmbh,
Cannaflos Gmbh,
Oceansafe,
Seegene Germany Gmbh,
Ab Enzymes,
Phesi,
Boehringer Ingelheim,
Next Generation Sequencing Competence Network,
Bio.nrw.
Liqomics's categories are Medical and Diagnostic Laboratories
Liqomics's founding year is 2021
